Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high on Tuesday . The company traded as high as GBX 117 and last traded at GBX 116.40, with a volume of 2054494 shares. The stock had previously closed at GBX 116.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reissued a “hold” rating and set a GBX 101 price target on shares of Target Healthcare REIT in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of GBX 101.
View Our Latest Stock Report on THRL
Target Healthcare REIT Stock Performance
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Further Reading
- Five stocks we like better than Target Healthcare REIT
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
